Menu
GeneBe

5-107387757-C-G

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001962.3(EFNA5):c.433G>C(p.Asp145His) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

EFNA5
NM_001962.3 missense

Scores

1
2
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.64
Variant links:
Genes affected
EFNA5 (HGNC:3225): (ephrin A5) Ephrin-A5, a member of the ephrin gene family, prevents axon bundling in cocultures of cortical neurons with astrocytes, a model of late stage nervous system development and differentiation. The EPH and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, particularly in the nervous system. EPH receptors typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin ligands and receptors have been named by the Eph Nomenclature Committee (1997). Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are similarly divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.18304324).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
EFNA5NM_001962.3 linkuse as main transcriptc.433G>C p.Asp145His missense_variant 3/5 ENST00000333274.11
EFNA5NM_001410773.1 linkuse as main transcriptc.433G>C p.Asp145His missense_variant 3/4
EFNA5XM_011543250.4 linkuse as main transcriptc.379G>C p.Asp127His missense_variant 3/5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
EFNA5ENST00000333274.11 linkuse as main transcriptc.433G>C p.Asp145His missense_variant 3/51 NM_001962.3 P3
EFNA5ENST00000509503.1 linkuse as main transcriptc.433G>C p.Asp145His missense_variant 3/45 A1
EFNA5ENST00000510359.1 linkuse as main transcriptn.81G>C non_coding_transcript_exon_variant 2/43

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 28, 2024The c.433G>C (p.D145H) alteration is located in exon 3 (coding exon 3) of the EFNA5 gene. This alteration results from a G to C substitution at nucleotide position 433, causing the aspartic acid (D) at amino acid position 145 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Benign
-0.10
T
BayesDel_noAF
Benign
-0.38
Cadd
Uncertain
24
Dann
Benign
0.85
DEOGEN2
Benign
0.0069
T;T;.
Eigen
Benign
-0.11
Eigen_PC
Benign
0.14
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.89
D;D;D
M_CAP
Benign
0.0055
T
MetaRNN
Benign
0.18
T;T;T
MetaSVM
Benign
-1.1
T
MutationTaster
Benign
1.0
D;D
PrimateAI
Pathogenic
0.80
T
Sift4G
Benign
1.0
T;T;T
Polyphen
0.0020
.;B;.
Vest4
0.29, 0.31
MutPred
0.40
.;Gain of MoRF binding (P = 0.0602);Gain of MoRF binding (P = 0.0602);
MVP
0.28
MPC
0.82
ClinPred
0.44
T
GERP RS
5.7
Varity_R
0.45
gMVP
0.43

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr5-106723458; API